Clinical trial
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on…
NCT00461006 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00461006 |
|---|---|
| Title | A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. |
| Official title | A Randomized, Double Blind Study to Compare the Effects of Aleglitazar and Actos on Glomerular Filtration Rate and Other Parameters of Renal Function in Patients With Type 2 Diabetes. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | Actos, aleglitazar |
| Enrollment | 176 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 17, 2007 |
| Last update posted | Aug 1, 2016 |
| Countries | Mexico, Puerto Rico, Russia, Ukraine, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: